Publication:
An Open, Non Comparative Study of Ofloxacin I.V. on the Treatment of Acute Symptomatic Urinary Tract Infection

Simple item page
dc.contributor.authorKorntong Asvanichen_US
dc.contributor.authorVichai Fugpholngamen_US
dc.contributor.authorSomboon Srimuangen_US
dc.contributor.authorDeja Tanphaichitraen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-09-07T09:19:21Z
dc.date.available2018-09-07T09:19:21Z
dc.date.issued2000-07-01en_US
dc.description.abstractThe clinical efficacy and the safety of ofloxacin I.V. in 35 acute symptomatic urinary tract patients were evaluated. The drug was intravenously administered, 400 mg starting dose then 200 mg once-daily for 3-5 days. The therapeutic success rate and eradication rate in UTI case were 100 per cent in all cases when evaluated immediately after completion of drug treatment, therapeutic success rate and eradication rate at the follow-up evaluation were 97.2 per cent and 91.6 per cent respectively. Also, 5 cases of acute bronchitis and 2 salmonellosis were also administered intravenously, 400 mg once-daily dose and 400 mg twice daily dose respectively. No serious side effects of ofloxacin I.V. therapy were observed in any of our patients.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.83, No.7 (2000), 771-775en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-0034218806en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/26207
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034218806&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleAn Open, Non Comparative Study of Ofloxacin I.V. on the Treatment of Acute Symptomatic Urinary Tract Infectionen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034218806&origin=inwarden_US

Files

Collections

Scopus 1991-2000